Cargando…
Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics
Estradiol (E2) and the oestrogen receptor-alpha (ERα) signalling pathway play pivotal roles in the proliferative activity of breast cancer cells. Recent findings show that the brefeldin A-inhibited guanine nucleotide-exchange protein 3-prohibitin 2 (BIG3-PHB2) complex plays a crucial role in E2/ERα...
Autores principales: | Yoshimaru, Tetsuro, Aihara, Keisuke, Komatsu, Masato, Matsushita, Yosuke, Okazaki, Yasumasa, Toyokuni, Shinya, Honda, Junko, Sasa, Mitsunori, Miyoshi, Yasuo, Otaka, Akira, Katagiri, Toyomasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431889/ https://www.ncbi.nlm.nih.gov/pubmed/28500289 http://dx.doi.org/10.1038/s41598-017-01951-6 |
Ejemplares similares
-
Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
por: Yoshimaru, Tetsuro, et al.
Publicado: (2015) -
Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions
por: Yoshimaru, Tetsuro, et al.
Publicado: (2014) -
A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2017) -
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells
por: Kim, Nam-Hee, et al.
Publicado: (2015) -
Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin‐containing protein inhibitor
por: Shikata, Yuki, et al.
Publicado: (2017)